Protein-leaking membranes for hemodialysis: A new class of membranes in search of an application?

Journal of the American Society of Nephrology

Volumn 16, Issue 8, 2005, Pages 2421-2430

  Ward, Richard A ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLYCOSYLATED PROTEIN; HOMOCYSTEINE; UREMIC TOXIN;

ANEMIA; ARTICLE; CLINICAL TRIAL; DIALYSIS MEMBRANE; EQUIPMENT DESIGN; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYPERHOMOCYSTEINEMIA; METABOLIC CLEARANCE RATE; OUTCOMES RESEARCH; OXIDATION; PRIORITY JOURNAL;

EID: 28444451861     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005010070     Document Type: Article

References (58)

1. Vanholder R, de Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jörres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W: Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 63: 1934-1943, 2003
2. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
3. Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan G: Effects of high-flux hemodialysis on clinical outcomes: Results of the HEMO study. J Am Soc Nephrol 14: 3251-3263, 2003
4. Miyata T, Jadoul M, Kurokawa K, van Ypersele de Strihou C: Beta-2 microglobulin in renal disease. J Am Soc Nephrol 9: 1723-1735, 1998
5. Himmelfarb J, McMonagle E: Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 60: 358-363, 2001
6. Ward RA, Brinkley KA: A proteomic analysis of proteins removed by ultrafiltration during extracorporeal renal replacement therapy. Contrib Nephrol 141: 280-291, 2004
7. Witko-Sarsat V, Friedlander M, Khoa TN, Capeillère-Blandin C, Nguyen AT, Canteloup S, Dayer J-M, Jungers P, Drüeke T, Descamps-Latscha B: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161: 2524-2532, 1998
8. Niwa T, Yazawa T, Kodama T, Uehara Y, Maeda K, Yamada K: Efficient removal of albumin-bound furancarboxylic acid, an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis. Nephron 56: 241-245, 1990
9. Dou L, Bertrand E, Cerini C, Faure V, Sampol J, Vanholder R, Berland Y, Brunet P: The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 65: 442-451, 2004
10. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006, 1993
11. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7: 728-736, 1996
12. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM: Amino acid and albumin losses during hemodialysis. Kidney Int 46: 830-837, 1994
13. Kaplan AA, Halley SE, Lapkin RA, Graeber CW, Graeber CA: Dialysate protein losses with bleach processed polysulfone dialyzers. Kidney Int 47: 573-578, 1995
14. Osicka TM, Houlihan CA, Chan JG, Jerums G, Comper WD: Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes 49: 1579-1584, 2000
15. Clavant SP, Comper WD: Urinary clearance of albumin is critically determined by its tertiary structure. J Lab Clin Med 142: 372-384, 2003
16. Kaysen GA, Rathore V, Shearer GC, Depner TA: Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 48: 510-516, 1995
17. Kaysen GA: Biological basis of hypoalbuminemia in ESRD. J Am Soc Nephrol 9: 2368-2376, 1998
18. Kaysen GA, Dubin JA, Müller H-G, Mitch WE, Resales LM, Levin NW: Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int 61: 2240-2249, 2002
19. Caravaca F, Arrobas M, Dominguez C: Serum albumin and other serum protein fractions in stable patients on peritoneal dialysis. Pent Dial Int 20: 703-707, 2000
20. Strathmann H, Göhl H: Membranes for blood purification: State of the art and new developments. Contrib Nephrol 78: 119-141, 1990
21. Colton CK, Lowrie EG: Hemodialysis: Physical principles and technical considerations. In: The Kidney, 2nd Ed., edited by Brenner BM, Rector FC, Philadelphia, WB Saunders, 1981, pp 2425-2489
22. Kim S-T: Characteristics of protein removal in hemodiafiltration. Contrib Nephrol 108:23-37, 1994
23. Ronco C, Brendolan A, Feriani M, Milan M, Conz P, Lupi A, Berto P, Bettini M, La Greca G: A new scintigraphic method to characterize ultrafiltration in hollow fiber dialyzers. Kidney Int 41: 1383-1393, 1992
24. Ronco C, Brendolan A, Lupi A, Metry G, Levin NW: Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Kidney Int 58: 809-817, 2000
25. Ledebo I: On-line hemodiafiltration: Technique and therapy. Adv Ren Replace Ther 6: 195-208, 1999
26. Sombolos K, Tsitamidou Z, Kyriazis G, Karagianni A, Kantaropoulou M, Progia E: Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo. Am J Nephrol 17: 406-412, 1997
27. Arenholz PG, Winkler RE, Michelsen A, Lang DA, Bowry SK: Dialysis membrane-dependent removal of middle molecules during hemodiafiltration: The beta2-microglobulin/albumin ratio. Clin Nephrol 62: 21-28, 2004
28. Shinzato T, Miwa M, Nakai S, Takai I, Matsumoto Y, Morita H, Miyata T, Maeda K: Alternate repetition of short fore- and backfiltrations reduces convective albumin loss. Kidney Int 50: 432-435, 1996
29. Santoro A, Canova C, Mancini E, Deppisch R, Beck W: Protein loss in on-line hemofiltration. Blood Purif 22: 261-268, 2004
30. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y: Removal of the protein-bound solute p-cresol by convective transport: A randomized crossover study. Am J Kidney Dis 44: 278-285, 2004
31. Ward RA: Ultrapure dialysate. Semin Dial 17: 489-497, 2004
32. Weber V, Linsberger I, Rossmanith E, Weber C, Falkenhagen D: Pyrogen transfer across high- and low-flux hemodialysis membranes. Artif Organs 28: 210-217, 2004
33. Niwa T, Asada H, Tsutsui S, Miyazaki T: Efficient removal of albumin-bound furancarboxylic acid by protein-leaking hemodialysis. Am J Nephrol 15: 463-467, 1995
34. Locatelli F, Andrulli S, Pecchini F, Pedrini L, Agliata S, Lucchi L, Farina M, La Milia V, Grassi C, Borghi M, Redaelli B, Conte F, Ratto G, Cabiddu G, Grossi C, Modense R: Effect of high-flux dialysis on the anaemia of haemodialysis patients. Nephrol Dial Transplant 15: 1399-1409, 2000
35. Stein G, Franke S, Mahiout A, Schneider S, Sperschneider H, Borst S, Vienken J: Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients. Nephrol Dial Transplant 16: 999-1008, 2001
36. van Tellingen A, Grooteman MPC, Bartels PCM, van Limbeek J, van Guldener C, ter Wee PM, Nubé MJ: Long-term reduction in plasma homocysteine levels by super-flux dialyzers in hemodialysis patients. Kidney Int 59: 342-347, 2001
37. De Vriese AS, Langlois M, Bernard D, Geerolf I, Stevens L, Boelaert JR, Schurgers M, Matthys E: Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients. Nephrol Dial Transplant 18: 2596-2600, 2003
38. Galli F, Benedetti S, Buoncristiani U, Piroddi M, Conte C, Canestrari F, Buoncristiani E, Floridi A: The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels. Kidney Int 64: 748-755, 2003
39. Tessitore N, Lapolla A, Aricò NC, Poli A, Gammaro L, Bassi A, Bedogna V, Corgnati A, Reitano R, Fedele D, Lupo A: Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels. J Nephrol 17: 707-714, 2004
40. Galli F, Benedetti S, Floridi A, Canestrari F, Piroddi M, Buoncristiani E, Buoncristiani U: Glycoxidation and inflammatory markers in patients on treatment with PMMA-based protein-leaking dialyzers. Kidney Int 67: 750-759, 2005
41. Galli F, Beninati S, Benedetti S, Lentini A, Canestrari F, Tabilio A, Buoncristiani U: Polymeric protein-polyamine conjugates: A new class of uremic toxins affecting erythropoiesis. Kidney Int 59[Suppl 78]: S73-S76, 2001
42. Bonomini M, Fiederling B, Bucciarelli T, Manfrini V, Di Ilio C, Albertazzi A: A new polymethylmethacrylate membrane for hemodialysis. Int J Artif Organs 19: 232-239, 1996
43. Sitter T, Bergner A, Schiffl H: Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant 15: 1207-1211, 2000
44. Arnadottir M, Berg A-L, Hegbrant J, Hultberg B: Influence of haemodialysis on plasma total homocysteine concentration. Nephrol Dial Transplant 14: 142-146, 1999
45. Meert N, Beerenhout C, De Smet R, Kooman J, Vanholder R: Removal of protein-bound uremic solutes by predilution on-line hemofiltration [Abstract]. J Am Soc Nephrol 15: 363A, 2004
46. De Smet R, Van Kar J, Van Vlem B, De Cubber A, Brunet P, Lameire N, Vanholder R: Toxicity of free p-cresol: A prospective and cross-sectional analysis. Clin Chem 49: 470-478, 2003
47. Miyata T, Ueda Y, Shinzato T, Iida Y, Tanaka S, Kurokawa K, van Ypersele de Strihou C, Maeda K: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7: 1198-1206, 1996
48. Smolin LA, Benevenga NJ: The use of cyst(e)ine in the removal of protein-bound homocysteine. Am J Clin Nutr 39: 730-737, 1984
49. Capeillère-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V: Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 1689: 91-102, 2004
50. Maduell F, del Pozo C, Garcia H, Sanchez L, Hdez-Jaras J, Albero MD, Calvo C, Torregrosa I, Navarro V: Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant 14: 1202-1207, 1999
51. Bonforte G, Grillo P, Zerbi S, Surian M: Improvement of anemia in hemodialysis patients treated by hemodiafiltration with high-volume on-line-prepared substitution fluid. Blood Pnrif 20: 357-363, 2002
52. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W: A comparison of on-line hemodiafiltration and high-flux hemodialysis: A prospective clinical study. J Am Soc Nephrol 11: 2344-2350, 2000
53. Gonella M, Calabrese G, Mengozzi A, Aleo AG, Vagelli G, Mazzotta A, Deambrogio P: The achievement of normal homocysteinemia in regular extracorporeal dialysis patients. J Nephrol 17: 411-413, 2004
54. Maduell F, Navarro V, Torregrosa E, Rius A, Dicenta F, Cruz MC, Ferrero JA: Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int 64: 305-313, 2003
55. Krieter DH, Canaud B: High permeability of dialysis membranes: What is the limit of albumin loss? Nephrol Dial Transplant 18: 651-654, 2003
56. Samtleben W, Dengler C, Reinhardt B, Nothdurft A, Lemke H-D: Comparison of the new polyethersulfone high-flux membrane DIAPES HF800 with conventional high-flux membranes during on-line haemodiafiltration. Nephrol Dial Transplant 18: 2382-2386, 2003
57. Wizemann V, Lotz C, Techert F, Uthoff S: On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study. Nephrol Dial Transplant 15[Suppl 1]: 43-48, 2000
58. Combarnous F, Tetta C, Cellier CC, Wratten ML, Custaud MA, De Catheu T, Fouque D, David S, Carraro G, Laville M: Albumin loss in on-line hemodiafiltration. Int J Artif Organs 25: 203-209, 2002